IQV
IQVIA Holdings Inc.Healthcare · $44.3B market cap
Verdict
Share price
$258.21
close of Oct 3, 2026
Fair value
$187.30
Sticker Price
Payback Price
$74.92
buy price
IQV is Overpriced: at $258.21 it trades 38% above its fair value of $187.30. Its buy price (Payback Price) is $74.92, 71% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.
How we valued it
Free Cash Flow. Sales grew 4% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.
Business quality
3 of 5 clear the 10% bar. What are the Big Five?
Follow IQV
Get notified when it reaches its buy price of $74.92. Free.
Create a free accountSuperinvestors
4 of the investors we track hold IQV. In Q2 2026, 1 opened a position and 1 sold out. Who we track
Insider activity
Since Jul 14, 2026: no open-market purchases, 9 sales worth $29.9M and 9 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Berkshire James G.
See Remarks · 2026-09-02
Sold
$697K
STAUB W RICHARD
See Remarks · 2026-08-03
Sold
$1.3M
Patel Bhavik
See Remarks · 2026-07-31
Sold
$436K
BOUSBIB ARI
See Remarks · 2026-07-29
Sold
$13.0M
BOUSBIB ARI
See Remarks · 2026-07-29
Sold
$10.8M
Other filings
About IQVIA Holdings Inc.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales &…
Medical - Diagnostics & Research
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works